1. Timing in administration of a heat-killed Lactobacillus casei preparation for radioprotection in mice.
- Author
-
Tsuneoka K, Ishihara H, Dimchev AB, Nomoto K, Yokokura T, and Shikita M
- Subjects
- Adjuvants, Immunologic pharmacology, Animals, Male, Mice, Mice, Inbred C3H, Radiation-Protective Agents pharmacology, Adjuvants, Immunologic administration & dosage, Lacticaseibacillus casei, Radiation-Protective Agents administration & dosage
- Abstract
A single subcutaneous injection of a preparation of heat-killed Lactobacillus casei (LC 9018), given before or after irradiation, significantly increased the survival rate of mice that had received 8.5-Gy 137Cs whole-body gamma-irradiation. A similar radioprotective effect was observed when LC 9018 was administered within the period from 2 days before irradiation to 9 h after irradiation, the pre-irradiation treatment being slightly better than the post-irradiation treatment. Increases in the weight of the spleen and in the number of endogenous spleen colonies on days 8 and 12 after irradiation suggested that the radioprotective effect was based on enhanced recovery of hematopoietic tissues. The activity of macrophage colony-stimulating factor (M-CSF) in serum was rapidly increased by the treatment and was maintained at the elevated level for 13 days. At the same time, an increased level of M-CSF mRNA was detected in the livers of the treated mice. However, LC 9018 failed to save the lives of mice when administered 3 days after irradiation, although it increased serum M-CSF as effectively as noted above. The small advantage of the pre-irradiation over the post-irradiation treatment was not explained by the increases of metallothionein in the hematopoietic tissues of the treated mice.
- Published
- 1994
- Full Text
- View/download PDF